INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

76,342 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Tax withholding
F$124K
4,329 sh
Aug 12, 2026Aug 14, 2026
Page 644 of 1909
← PrevNext →
traded Aug 12, 2026
+2d
SEC Form 4

Evidence

12
SM
Stevenson MatthewDirector, President and CEO
HLLYHolley Inc.
Tax withholding
F$180K
56.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Option exercise
M$79K
6,250 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
HM
Howell Stephen Mitchell Jr.COO
RIOTRiot Platforms, Inc.
Gift
G—
21.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
LP
Loop PaulaDirector
FSLYFastly, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
7,332 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
SC
Sciarra Paul CahillDirector
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$498K
62.5K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
600 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$214K
972 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
757 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$227K
1,022 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

11
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise
M$273K
15.0K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

10
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$855K
16.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
WB
Wells David BDirector
HIMSHims & Hers Health, Inc.
Grant or award
A—
778 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
BD
Baetz Cary DEVP and CFO
INRINFINITY NATURAL RESOURCES, INC.
Grant or award
A—
31.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
EM
Elshenawy MohamedCTO
HIMSHims & Hers Health, Inc.
Grant or award
A—
1.20M sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Option exercise
M—
78.7K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
MA
Manuel AnjaDirector
HIMSHims & Hers Health, Inc.
Grant or award
A—
8,223 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
100.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
50.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Option exercise
M—
57.1K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
WB
Wells David BDirector
HIMSHims & Hers Health, Inc.
Grant or award
A—
8,223 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
SK
Schultz KareDirector
HIMSHims & Hers Health, Inc.
Grant or award
A—
8,223 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
NM
Nofi MichaelChief Financial Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
48.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Tax withholding
F$37K
797 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Option exercise
M—
272.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

9
VA
Villanueva Rodriguez AlfonsoEVP and Group CEO-VZ Consumer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,738
126 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
BH
Bradshaw James HendersonDirector
RLIRLI CORP
Grant or award
A—
2,153 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
CM
Cosgrove Delos M.Director
HIMSHims & Hers Health, Inc.
Grant or award
A—
8,223 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
AO
Amoo-Gottfried Kofi OwusuDirector
HIMSHims & Hers Health, Inc.
Grant or award
A—
8,223 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Option exercise
M—
74.7K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
TJ
Taylor Randy JSee Remarks
USFDUS Foods Holding Corp.
Option exercise
M—
6,431 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
CJ
Colella JosephSVP and General Counsel
ENTGENTEGRIS INC
Option exercise
M—
3,916 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Option exercise
M—
1.00M sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

9
SL
Stillwell Mary-LeeSVP and Controller
VZVERIZON COMMUNICATIONS INC
Grant or award
A$584
42 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

9
TB
Trebbi BarbaraDirector
BLCOBausch & Lomb Corp
Grant or award
A—
11.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
750 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
1,650 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
BD
Baetz Cary DEVP and CFO
INRINFINITY NATURAL RESOURCES, INC.
Grant or award
A—
31.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Tax withholding
F$17K
363 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
CJ
Chersi Robert JDirector
BLCOBausch & Lomb Corp
Grant or award
A—
11.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence